San Diego, CA, United States of America

Drahoslay Lim

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1999.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Drahoslay Lim - Innovator in Topical Pain Relief

Introduction

Drahoslay Lim is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of pain relief through his innovative formulations. His work focuses on developing effective topical solutions that provide relief from pain.

Latest Patents

Drahoslay Lim holds a patent for a topical pain-relieving preparation that contains higher homologs of isoparaffins, specifically ranging from C.sub.12 to C.sub.18. This method involves topically applying an effective amount of these compounds to skin tissue. The compositions include isoparaffins mixed with at least one ingredient from the group consisting of salicylate, capsaicin, camphor, and menthol. Additional constituents may be incorporated to create creams or lotions. He has 1 patent to his name.

Career Highlights

Throughout his career, Drahoslay Lim has focused on creating innovative solutions for pain management. His dedication to research and development has led to advancements in topical applications that enhance patient comfort and well-being.

Collaborations

Drahoslay Lim has worked alongside Erich A Koeniger, contributing to the development of effective pain relief products. Their collaboration has fostered innovation in the field.

Conclusion

Drahoslay Lim's contributions to topical pain relief demonstrate his commitment to improving the quality of life for individuals suffering from pain. His innovative approach and patented formulations are a testament to his expertise in the field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…